Purpose. The purpose of the present study was to obtain a better understanding of the relationship between cell surface physiology and outer cellular envelope permeability for hydrophobic substances in mucoid and non-mucoid B. multivorans strains, as well as in two capsule-deficient derivatives of a mucoid parental strain.
Methodology. Cell surface hydrophobicity properties were determined using the hydrocarbon adherence method, while outer cell envelope accessibility and permeability for non-polar compounds were measured using hydrophobic antimicrobial agent susceptibility and fluorescent probe assays. Extracellular polysaccharide (EPS) production was assessed by cultivating strains of disparate origin on yeast extract agar (YEA) containing different sugars, while the resultant colonial and cellular morphological parameters were assessed macro- and microscopically, respectively.
Results/Key findings. The cell surfaces of all the strains were hydrophilic, impermeable to mechanistically disparate hydrophobic antibacterial agents and inaccessible to the hydrophobic probe N-phenyl-1-napthylamine, regardless of EPS phenotype. Supplementation of basal YEA with eight different sugars enhanced macroscopic EPS expression for all but one non-mucoid strain, with mannose potentiating the greatest effect. Despite acquisition of the mucoid phenotype, non-mucoid strains remained non-capsulated and capsulation of a hyper-mucoid strain and its two non-mucoid derivative strains was unaffected, as judged by microscopic observation.
Conclusion. These data support the conclusion that EPS expression and the consistent mucoid phenotype are not necessarily associated with the ability of the outer cell surface to associate with non-polar substances or cellular capsulation.
VandammeP, HolmesB, VancanneytM, CoenyeT, HosteB et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol1997; 47:1188–1200 [View Article][PubMed]
de SmetB, MayoM, PeetersC, ZlosnikJE, SpilkerT et al.Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sources. Int J Syst Evol Microbiol2015; 65:2265–2271 [View Article][PubMed]
BertotGM, RestelliMA, GalanternikL, Aranibar UreyRC, ValvanoMA et al. Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia. Infect Immun2007; 75:2740–2752 [View Article][PubMed]
SistP, CescuttiP, SkerlavajS, UrbaniR, LeitãoJH et al. Macromolecular and solution properties of cepacian: the exopolysaccharide produced by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient. Carbohydr Res2003; 338:1861–1867 [View Article][PubMed]
KrejcíE, KroppenstedtRM. Differentiation of species combined into the Burkholderia cepacia complex and related taxa on the basis of their fatty acid patterns. J Clin Microbiol2006; 44:1159–1164 [View Article][PubMed]
TaylorCJ, AndersonAJ, WilkinsonSG. Phenotypic variation of lipid composition in Burkholderia cepacia: a response to increased growth temperature is a greater content of 2-hydroxy acids in phosphatidylethanolamine and ornithine amide lipid. Microbiology1998; 144:1737–1745 [View Article][PubMed]
IeranòT, SilipoA, SturialeL, GarozzoD, BrookesH et al. The structure and proinflammatory activity of the lipopolysaccharide from Burkholderia multivorans and the differences between clonal strains colonizing pre and posttransplanted lungs. Glycobiol2008; 18:871–881 [View Article][PubMed]
HerasimenkaY, CescuttiP, ImpallomeniG, CampanaS, TaccettiG et al. Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex. J Cyst Fibros2007; 6:145–152 [View Article][PubMed]
CuzziB, HerasimenkaY, SilipoA, LanzettaR, LiutG et al. Versatility of the Burkholderia cepacia complex for the biosynthesis of exopolysaccharides: a comparative structural investigation. PLoS One2014; 9:e94372 [View Article][PubMed]
ConwayBA, ChuKK, BylundJ, AltmanE, SpeertDP. Production of exopolysaccharide by Burkholderia cenocepacia results in altered cell-surface interactions and altered bacterial clearance in mice. J Infect Dis2004; 190:957–966 [View Article][PubMed]
SilvaIN, TavaresAC, FerreiraAS, MoreiraLM. Stress conditions triggering mucoid morphotype variation in Burkholderia species and effect on virulence in Galleria mellonella and biofilm formation in vitro. PLoS One2013; 8:e82522 [View Article][PubMed]
EllisonML, ChamplinFR. Outer membrane permeability for nonpolar antimicrobial agents underlies extreme susceptibility of Pasteurella multocida to the hydrophobic biocide triclosan. Vet Microbiol2007; 124:310–318 [View Article][PubMed]
WattJM, WadeMM, HolmanSC, WilsonWW, KeilDE et al. Influence of serotype A capsulation on cell surface physiologic factors in Pasteurella multocida. Colloids Surf B Biointerfaces2003; 28:227–238 [View Article]